News Focus
News Focus
Followers 269
Posts 18896
Boards Moderated 0
Alias Born 01/19/2006

Re: biopharm post# 307836

Friday, 08/11/2017 4:17:53 AM

Friday, August 11, 2017 4:17:53 AM

Post# of 347009
Biopharm, we will leave all the questions you raise for each entity, and their respective attys, to figure out and negotiate as necessary. On the ???s of patentabilities of subject matters, those are questions best left to respective Attys working with respective patent offices(courts if necessary) to ascertain. Those questions cannot, should not, be attempted to be resolved by us here, simply because we do not have all the facts immediately in front of us.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y